Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone 750 mg Tablets
Teva Pharmaceuticals USA has recalled a single lot of Nabumetone 750 mg tablets. Lot number 05N533 is being recalled because there were missing labels and leaflets. Nabumetone is often used in the treatment of pain. This recall alert only applies to the single lot of the generic Nabumetone Tablets, 750 mg made by Teva Pharmaceuticals USA. No other nabumetone products were involved in this recall. To search for an view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/ires/index.cfm
Learn More

Los Profesionales Sanitarios Informados: Viekirax (Ombitasvir, Paritaprevir, Ritonavir) No Recomendado En Pacientes Con Determinados Problemas En El Hígado
AbbVie ha escrito a los profesionales sanitarios para informarles sobre la nueva medida de seguridad disponible acerca de la administración de Viekirax (ombitasvir, paritaprevir, ritonavir) ya que se han notificado casos de insuficiencia hepática (hígado dañado e incapaz de funcionar plenamente) en pacientes tratados con Viekirax, con o sin Exviera (dasabuvir). En algunos de estos casos los pacientes fallecieron o llegaron a precisar un trasplante de hígado. No se recomienda administrar Viekirax (ombitasvir, paritaprevir, ritonavir), sólo o en combinación con Exviera (dasabuvir), en pacientes con insuficiencia hepática moderada y permanece contraindicado en pacientes con insuficiencia hepática grave. En pacientes con cirrosis a los que se les vaya a administrar Viekirax, con o sin Exviera, se deberá vigilar la aparición de signos o síntomas de descompensación en el hígado durante el tratamiento, y controlar la función del hígado mediante pruebas antes de comenzar el tratamiento, durante las primeras 4 semanas y posteriormente cuando esté clínicamente indicado. Viekirax (ombitasvir, paritaprevir, ritonavir) y Exviera (dasabuvir) son dos medicamentos antivirales indicados, en combinación con otros medicamentos, para el tratamiento de la hepatitis C crónica en adultos. Para más información puede visitar: https://sinaem.agemed.es/CartasFarmacovigilanciaDoc/2016/Viekirax-Exviera-DHCP-carta-2016-01-04.pdf
Learn More

Date Published Title Medicine Source
2016-07-06 Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone 750 mg Tablets Nabumetone FDA
2016-02-03 Los Profesionales Sanitarios Informados: Viekirax (Ombitasvir, Paritaprevir, Ritonavir) No Recomendado En Pacientes Con Determinados Problemas En El Hígado AEMPS
2015-05-28 RelonChem Recalls All Unexpired Tramadol 50mg Capsules Over Fungal Contamination Risk Tramadol MHRA
2015-02-19 Healthcare Professionals Advised of New Law that Sets Blood Concentration Limits for Certain Drugs When Driving Methadone MHRA
2015-02-19 MHRA Advises Healthcare Professionals that Spiriva Respimat and Handihaler Have Similar Benefits and Risks Tiotropium MHRA
2015-02-19 Clinigen Advises Healthcare Professionals About Vibativ Safety Concerns MHRA
2015-02-19 Healthcare Professionals Advised Not to Use Erivedge in Women of Childbearing Potential MHRA
2015-02-17 MHRA Advises Lowest Effective Dose of HRT Should Be Used for Shortest Possible Time Ethinylestradiol MHRA
2014-11-12 Glaxo SmithKline Recalls Zovirax Eye Ointment Over Impurities Aciclovir MHRA
2014-09-05 Motilium No Longer Available Over the Counter Without a Prescription Domperidone MHRA
2014-07-02 Procoralan Linked to Potential Risk of Heart Attack and Stroke in Patients with Slow Heart Beat Ivabradine MHRA
2014-07-02 Healthcare Professionals Reminded of the Risks of Accidental Exposure to Fentanyl Patches Fentanyl MHRA
2014-07-02 Healthcare Professionals Advised About Safety Concerns with Vibativ MHRA
2014-06-12 MHRA Advises Users to Following Instructions for Accu-Chek Blood Glucose Meters Insulin Aspart MHRA
2014-06-06 Healthcare Professionals Advised of Restrictions in Use of Domperidone Domperidone MHRA
2014-06-06 Healthcare Professionals Advised of Strengthened Warnings for Use of Adrenaline Pens Primatene MHRA
2014-06-06 Healthcare Professionals Given Latest Summary of Benefits and Risks of Statins Simvastatin MHRA
2014-06-06 Healthcare Professionals Advised that Zolpidem Impairs Driving Ability Next Day Zolpidem MHRA
2014-03-27 European Medicines Agency Recommends Restricting Strontium Use Because of Heart Disease Risk Strontium Ranelate EMEA
2014-03-26 New Pipette Design Launched for Cosopt Preservative-Free Eye Drops Dorzolamide Hydrochloride with Timolol Maleate MHRA